Implantica publishes Interim Report Q3, January-September 2020

Implantica publishes Interim Report Q3, January-September 2020

PR Newswire

STOCKHOLM, Nov. 18, 2020

STOCKHOLM , Nov. 18, 2020 /PRNewswire/ -- "It is with great pleasure that we provide our first quarterly report since listing on Sweden's Nasdaq First North Premier Growth Market on 21 September."

- Peter Forsell, CEO and Founder of Implantica AG

Significant events during the third quarter, 2020

Significant events after the end of the reporting period

July - September 2020

January - September 2020

Implantica will hold a telephone conference on November 18 at 10:30 CET

To participate, please dial:
Sweden: +46850558369 
United Kingdom: +443333009260
United States: +18338230587
Webcast: https://tv.streamfabriken.com/2020-11-18-implantica 

For further information, please contact:

Nicole Pehrsson, Investor Relations
Telephone (CH): +41 (0)79 335 09 49
nicole.pehrsson@implantica.com

Implantica is listed on Nasdaq First North Premier Growth Market in Stockholm.

The company's Certified Adviser is FNCA Sweden AB, +46 (0)8 528 00 399, info@fnca.se

The information was sent for publication, through the agency of the contact person set out above, on November 18, 2020 at 08:00 a.m. CET.

About Implantica

Implantica is a medtech group dedicated to bringing advanced technology into the body. Implantica's lead product, RefluxStop™, is a CE-marked implant for the prevention of gastroesophageal reflux that will potentially create a paradigm shift in anti-reflux treatment as supported by successful clinical trial results. Implantica also focuses on eHealth inside the body and has developed a broad, patent protected, product pipeline based partly on two platform technologies: an eHealth platform designed to monitor a broad range of health parameters, control treatment from inside the body and communicate to the caregiver on distance and a wireless energising platform designed to power remote controlled implants wirelessly through intact skin. Implantica is listed on Nasdaq First North Premier Growth Market (ticker: IMP A SDB). Visit www.implantica.com for further information.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/implantica/r/implantica-publishes-interim-report-q3--january-september-2020,c3238979

The following files are available for download:

https://mb.cision.com/Main/19732/3238979/1336435.pdf

Interim Report January - September 2020

https://mb.cision.com/Public/19732/3238979/9fb58ee6ed474dbe.pdf

Implantica publishes Interim Report Q3 January-September 2020

 

Voltar noticias em Inglês